| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 24, 2020 | Nov 25, 2020 | Stoke Therapeutics, Inc. | 10% Owner | Buy | 90.0 | +375,000 | 2.23% | ✗ | $14.6M |
| Jul 10, 2020 | Jul 14, 2020 | Akero Therapeutics, Inc. | 10% Owner | Buy | 97.5 | +415,000 | 7.66% | ✗ | $14.9M |
| Jun 24, 2019 | Jun 25, 2019 | Akero Therapeutics, Inc. | 10% Owner | Buy | 100.0 | +900,000 | 19.93% | ✗ | $14.4M |
| Jun 21, 2019 | Jun 21, 2019 | Stoke Therapeutics, Inc. | 10% Owner | Buy | 97.5 | +1,388,889 | 9.02% | ✗ | $25M |